Precigen, Inc. Files 8-K on Financials
Ticker: PGEN · Form: 8-K · Filed: Nov 13, 2025 · CIK: 1356090
| Field | Detail |
|---|---|
| Company | Precigen, Inc. (PGEN) |
| Form Type | 8-K |
| Filed Date | Nov 13, 2025 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: financials, 8-K, company-update
Related Tickers: PGEN
TL;DR
Precigen (PGEN) filed an 8-K on Nov 13, 2025, updating financials. Formerly Intrexon.
AI Summary
Precigen, Inc. filed an 8-K on November 13, 2025, reporting on its Results of Operations and Financial Condition, as well as Financial Statements and Exhibits. The filing pertains to the period ending November 13, 2025. Precigen, Inc. was formerly known as Intrexon Corp.
Why It Matters
This 8-K filing provides an update on Precigen, Inc.'s financial condition and results of operations, which is crucial information for investors to assess the company's performance and outlook.
Risk Assessment
Risk Level: low — This is a routine financial filing and does not appear to contain any immediate or significant new risks.
Key Players & Entities
- Precigen, Inc. (company) — Registrant
- November 13, 2025 (date) — Date of earliest event reported
- Intrexon Corp (company) — Former company name
FAQ
What is the primary purpose of this 8-K filing for Precigen, Inc.?
The primary purpose of this 8-K filing is to report on Precigen, Inc.'s Results of Operations and Financial Condition, as well as Financial Statements and Exhibits.
On what date was the earliest event reported in this filing?
The earliest event reported in this filing was on November 13, 2025.
What was Precigen, Inc.'s former company name?
Precigen, Inc.'s former company name was Intrexon Corp.
In which state is Precigen, Inc. incorporated?
Precigen, Inc. is incorporated in Virginia.
What is the principal executive office address for Precigen, Inc.?
The principal executive office address for Precigen, Inc. is 20374 Seneca Meadows Parkway, Germantown, Maryland 20876.
Filing Stats: 478 words · 2 min read · ~2 pages · Grade level 10.2 · Accepted 2025-11-13 16:18:30
Filing Documents
- dp237316_8k.htm (8-K) — 21KB
- dp237316_ex9901.htm (EX-99.1) — 101KB
- image_001.jpg (GRAPHIC) — 2KB
- 0000950103-25-014683.txt ( ) — 299KB
- pgen-20251113.xsd (EX-101.SCH) — 3KB
- pgen-20251113_lab.xml (EX-101.LAB) — 33KB
- pgen-20251113_pre.xml (EX-101.PRE) — 22KB
- dp237316_8k_htm.xml (XML) — 3KB
02. Results of Operations and Financial
Item 2.02. Results of Operations and Financial Condition. Attached as Exhibit 99.1 is a copy of a press release of Precigen, Inc., dated November 13, 2025, reporting its financial results for the quarter ended September 30, 2025. This information, including the Exhibit attached hereto, shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, except as shall be expressly set forth by specific reference in such filing.
01. Financial Statements and Exhibits
Item 9.01. Financial Statements and Exhibits. (d) Exhibits. Exhibit No. Description 99.1 Press release dated November 13, 2025 104 Cover Page Interactive Data File (formatted as inline XBRL with applicable taxonomy extension information contained in Exhibits 101)
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Precigen, Inc. By: /s/ Donald P. Lehr Donald P. Lehr Chief Legal Officer Dated: November 13, 2025